INSP NYSE
Credit Risk of going bust: lower than 65% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.14 (down 99.8%), Inspire Medical Systems, Inc. would be worth roughly what it owes.
Total debt $29.1M against a stock market value of $2.05B.
Distance to default 6.88 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.5M (short-term plus half of long-term), stock volatility 69.7%; Altman Z 13.93. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Golden Valley, MN 55416
US
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Ellis Gary Lee | A-Award | 431 | $68.07 | 2026-10-14 |
| Melenikiotou Georgia | A-Award | 255 | $68.07 | 2026-10-14 |
| CARREL MICHAEL H | A-Award | 203 | $68.07 | 2026-10-14 |
| Broader Shelley G | A-Award | 284 | $68.07 | 2026-10-14 |
| Kelly Jason P | A-Award | 6,350 | — | 2026-08-31 |